CTI BIOPHARMA

CTI BioPharma Corp. a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin's lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P.

#SimilarOrganizations #People #Financial #Event #Website #More

CTI BIOPHARMA

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

1991-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.ctibiopharma.com

Total Employee:

251+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

185.76 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

agile-therapeutics-logo

Agile Therapeutics

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.

calithera-biosciences-logo

Calithera Biosciences

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

epizyme-logo

Epizyme

Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

galera-therapeutics-logo

Galera Therapeutics

Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.

Current Advisors List

ross-levine_image

Ross Levine Scientific Advisory Board @ CTI BioPharma
Advisor

not_available_image

Vartan Gregorian Board of Directors @ CTI BioPharma
Board_member
2001-12-01

not_available_image

Mary O’Neil Mundinger Board of Directors @ CTI BioPharma
Board_member
1997-04-01

daniel-von-hoff_image

Daniel Von Hoff Chairman & Scientific Advisory Board @ CTI BioPharma
Advisor

reed-tuckson_image

Reed Tuckson Member of the Board of Directors @ CTI BioPharma
Board_member

victoria-saucier_image

Victoria Saucier Investor @ CTI BioPharma
Board_member

brian-druker_image

Brian Druker Member of the Scientific Advisory Board @ CTI BioPharma
Advisor

not_available_image

Alan List Scientific Advisory Board @ CTI BioPharma
Advisor

Current Employees Featured

not_available_image

David Kirske
David Kirske EVP, Chief Financial Officer @ CTI BioPharma
EVP, Chief Financial Officer

nancy-l-boman_image

Nancy L. Boman
Nancy L. Boman SVP, Clinical Development and Regulatory Affairs @ CTI BioPharma
SVP, Clinical Development and Regulatory Affairs

not_available_image

Adam Craig
Adam Craig President and CEO @ CTI BioPharma
President and CEO

bruce-seeley_image

Bruce Seeley
Bruce Seeley Chief Operating Officer @ CTI BioPharma
Chief Operating Officer
2017-09-01

matthew-plunkett_image

Matthew Plunkett
Matthew Plunkett EVP, Corporate Development @ CTI BioPharma
EVP, Corporate Development
2012-09-01

Founder

jack-w-singer_image

Jack W. Singer

james-a-bianco_image

James A. Bianco

louis-bianco_image

Louis Bianco

Stock Details

Company's stock symbol is NASDAQ:CTIC

Investors List

dri-healthcare-trust_image

Investments List

Date	Company	Article	Money raised
2016-02-10	Biowatch	CTI BioPharma investment in Grant - Biowatch	800 K CHF

Newest Events participated

Participated in Oncology Strategy Meeting US West Coast 2018 on 2018-05-14 as speaker

Official Site Inspections

http://www.ctibiopharma.com Semrush global rank: 1.91 M Semrush visits lastest month: 11.4 K

Host Informations
Whois Informations

Loading ...